Status:
NOT_YET_RECRUITING
Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's Lymphoma
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Fatigue Symptom
Lymphoma Non-Hodgkin
Eligibility:
All Genders
18+ years
Brief Summary
The incidence of cancer in 2023 is estimated at 433136 cases, according to INCa. Haemopathies account for 12% of these new cases of cancer cases of cancer, and around two-thirds are lymphoid haemopath...
Eligibility Criteria
Inclusion
- Adult (age\> 18year old)
- Person hospitalised for treatment with CAR-T Cells for non-Hodgkin's lymphoma.
- Person able to understand and read the French language.
Exclusion
- Patient under legal protection
- Opposition to research
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06890091
Start Date
April 1 2025
End Date
May 1 2026
Last Update
March 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.